NO20045496L - Anvendelse av nefopam for behandling av kvalme eller emesis - Google Patents

Anvendelse av nefopam for behandling av kvalme eller emesis

Info

Publication number
NO20045496L
NO20045496L NO20045496A NO20045496A NO20045496L NO 20045496 L NO20045496 L NO 20045496L NO 20045496 A NO20045496 A NO 20045496A NO 20045496 A NO20045496 A NO 20045496A NO 20045496 L NO20045496 L NO 20045496L
Authority
NO
Norway
Prior art keywords
nefopam
emesis
nausea
treatment
dizziness
Prior art date
Application number
NO20045496A
Other languages
English (en)
Norwegian (no)
Inventor
Robin Mark Bannister
Michael Harvey Lyne
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of NO20045496L publication Critical patent/NO20045496L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/5545Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having eight-membered rings not containing additional condensed or non-condensed nitrogen-containing 3-7 membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20045496A 2002-06-17 2004-12-16 Anvendelse av nefopam for behandling av kvalme eller emesis NO20045496L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0213869.1A GB0213869D0 (en) 2002-06-17 2002-06-17 The treatment of pain
PCT/GB2003/002586 WO2003105832A1 (en) 2002-06-17 2003-06-17 Use of nefopam for the treatment of nausea or emesis

Publications (1)

Publication Number Publication Date
NO20045496L true NO20045496L (no) 2005-01-12

Family

ID=9938718

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045496A NO20045496L (no) 2002-06-17 2004-12-16 Anvendelse av nefopam for behandling av kvalme eller emesis

Country Status (15)

Country Link
US (2) US20060040905A1 (es)
EP (2) EP1513518A1 (es)
JP (2) JP2005533784A (es)
CN (1) CN100482221C (es)
AU (2) AU2003240113B2 (es)
BR (1) BR0311874A (es)
CA (2) CA2489306A1 (es)
GB (1) GB0213869D0 (es)
IL (1) IL165773A0 (es)
MX (1) MXPA04012826A (es)
NO (1) NO20045496L (es)
NZ (1) NZ537197A (es)
PL (1) PL374418A1 (es)
WO (2) WO2003105833A1 (es)
ZA (1) ZA200410102B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0330049D0 (en) * 2003-12-24 2004-02-04 Arakis Ltd The treatment of neuropathic pain conditions
GB0408864D0 (en) * 2004-04-21 2004-05-26 Arakis Ltd Novel benzoxazocines
GB0515703D0 (en) * 2005-07-29 2005-09-07 Arakis Ltd Therapeutic use of nefopam
US8163761B2 (en) * 2007-06-22 2012-04-24 Hydra Biosciences, Inc. Methods and compositions for treating disorders
GB0721013D0 (en) 2007-10-25 2007-12-05 Sosei R & D Ltd New Salts
PT2293794E (pt) 2008-05-27 2013-07-10 Univ Melbourne Métodos de tratamento de mamíferos com disfunções da trompa de eustáquio
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
US8580730B2 (en) * 2009-05-20 2013-11-12 (Inserm) Institut National De La Sante Et De La Recherche Medicale Methods of treating lesional vestibular disorders by administering serotonin 5-HT3 receptor antagonists
CA2782472C (en) * 2009-12-15 2019-04-16 The Hospital For Sick Children Method of treating scars and beta-catenin-mediated disorders
US11612605B2 (en) 2016-04-14 2023-03-28 Sensorion (+)-azasetron for use in the treatment of ear disorders
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
PL3965834T3 (pl) * 2019-05-06 2024-04-29 Chemcom S.A. Zastosowanie kompozycji przeciwdziałającej nieprzyjemnemu zapachowi i związany z nią sposób

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59911149D1 (de) * 1998-07-24 2004-12-30 Jago Res Ag Muttenz Medizinische aerosolformulierungen
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane

Also Published As

Publication number Publication date
CN1668294A (zh) 2005-09-14
JP2005533784A (ja) 2005-11-10
CA2489315A1 (en) 2003-12-24
US20060040905A1 (en) 2006-02-23
ZA200410102B (en) 2006-07-26
AU2003277077A1 (en) 2003-12-31
CA2489306A1 (en) 2003-12-24
PL374418A1 (en) 2005-10-17
CN100482221C (zh) 2009-04-29
EP1513518A1 (en) 2005-03-16
MXPA04012826A (es) 2005-03-31
WO2003105833A1 (en) 2003-12-24
WO2003105832A1 (en) 2003-12-24
AU2003277077B2 (en) 2006-11-02
AU2003240113A1 (en) 2003-12-31
US20060063753A1 (en) 2006-03-23
IL165773A0 (en) 2006-01-15
BR0311874A (pt) 2005-05-10
EP1513517A1 (en) 2005-03-16
NZ537197A (en) 2007-10-26
AU2003240113B2 (en) 2006-11-16
GB0213869D0 (en) 2002-07-31
JP2005531612A (ja) 2005-10-20

Similar Documents

Publication Publication Date Title
NO20045496L (no) Anvendelse av nefopam for behandling av kvalme eller emesis
RS20060320A (en) Substituted indazole-o-glucosides
MY142777A (en) Substituted indole-o-glucosides
UA86042C2 (en) Substituted indazole-o-glucosides
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
DK1343782T3 (da) Pyrimidinaminer som angiogenesemodulatorer
NO20053041D0 (no) Behandling av diabetes.
WO2005012242A3 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
WO2003051886A8 (en) Pyrazolopyridazine derivatives
CY1110664T1 (el) Ενδορινικες συνθεσετς
BRPI0607351A2 (pt) métodos para tratamento de linfomas empregando uma combinação de agente quimioterapêutico e il-2 e opcionalmente um anticorpo anti-cd20
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
IL165790A0 (en) Cationically substituted diphenyl azetidinones method for their production medicaments containing said compounds and use thereof
TW200504402A (en) Antimicrobial lenses, processes to prepare them and methods of their use
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
UA85187C2 (en) 2-aminobenzoyl derivatives
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
RS20060323A (en) Substituted indole-o-glucosides
RS20050038A (en) Stabilization of the profile of release of active substances from a formulation
IL160490A0 (en) Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections
ITNA20020003A1 (it) Apparecchiatura per lo studio e la correzione della visione binoculare.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application